OC 24 - Managing Coagulopathy

Moderator(s)

• SS

  Simon Stanworth, DPhil FRCP FRCPath

  Professor
  Haematology
  Oxford University Hospitals/NHS Blood and Transplant
  Oxford, England, United Kingdom
• 

  Bethany Samuelson Bannow, MD

  Hematologist
  Medicine
  Oregon Health & Science University, Portland, Oregon, USA
  Portland, Oregon, United States

Presentations:

• 2:45 PM – 3:00 PM

  Synergy of red blood cells and tranexamic acid in the inhibition of fibrinolysis
  

  Presenting Author: Alexandra Raska, PhD – Semmelweis University, Department of Biochemistry, Department of Hematology and Internal Medicine, HCEMM-SU Thrombosis and Haemostasis Research Group

  Co-Author: Kata Kalman – Semmelweis University, Department of Biochemistry, HCEMM-SU Thrombosis and Haemostasis Research Group

  Co-Author: Barnabas Egri – Semmelweis University

  Co-Author: Ian Roberts, MD, PhD – Clinical Trials Unit, London School of Hygiene & Tropical Medicine

  Co-Author: Krasimir Kolev – Semmelweis University, Department of Biochemistry

  Co-Author: Nikolett Wohner – Semmelweis University, Department of Biochemistry, Department of Hematology and Internal Medicine, HCEMM-SU Thrombosis and Haemostasis Research Group
• 3:00 PM – 3:15 PM

  VALIDATION OF A TREATMENT DECISION ALGORITHM FOR THE USE OF ANDEXANET ALFA IN ACUTE LIFE-THREATENING BLEEDING FROM DIRCT FACTOR Xa INHIBITORS
  

  Presenting Author: Jan Beyer-Westendorf, MD,PhD – University Hospital “Carl Gustav Carus”, Technische Universität Dresden, Division of Hematology and Hemostasis, Department of Medicine I Thrombosis Research, Dresden, Saxony, Germany

  Co-Author: Jürgen Koscielny – Charité – Universitätsmedizin Berlin
• 3:15 PM – 3:30 PM

  VMX-C001 is an effective factor Xa inhibitor reversal agent and displays a favorable pharmacodynamic profile in animal models
  

  Presenting Author: Daniël Verhoef, PhD – 1VarmX, Leiden, The Netherlands. 2Division of Thrombosis and Hemostasis, Einthoven Laboratory for Vascular and Regenerative Medicine, Leiden University Medical Center, Leiden, The Netherlands.

  Co-Author: Tainá Gomes – 1VarmX, Leiden, The Netherlands

  Co-Author: Henri Spronk – 3 Maastricht University, Maastricht, The Netherlands.

  Co-Author: Ged Short – 1VarmX, Leiden, The Netherlands.

  Co-Author: Pieter H. Reitsma – 1VarmX, Leiden, The Netherlands. 2Division of Thrombosis and Hemostasis, Einthoven Laboratory for Vascular and Regenerative Medicine, Leiden University Medical Center, Leiden, The Netherlands.
• 3:30 PM – 3:45 PM

  Factor XIII levels correlate with fibrinogen concentrations in patients with venous malformations and chronic disseminated intravascular coagulopathy
  

  Presenting Author: Nick Fordham – Great Ormond Street Hospital for Children

  Co-Author: James Clark – Great Ormond Street Hospital for Children

  Co-Author: Alice Taylor – Great Ormond Street Hospital for Children

  Co-Author: Keith Sibson – Great Ormond Street Hospital for Children

  Co-Author: Lea Solman – Great Ormond Street Hospital for Children

  Co-Author: Mary Glover – Great Ormond Street Hospital for Children

  Co-Author: Mary Mathias – Great Ormond Street Hospital for Children, NHS Foundation Trust
• 3:45 PM – 4:00 PM

  Modest Performance of Available Risk Prediction Models when Used to Predict Hemorrhage in Patients with Chronic Liver Disease
  

  Presenting Author: Amber Afzal, MD, MSCI – Washington University in St Louis

  Co-Author: Luo Suhong – Washington University in St Louis

  Co-Author: Brian Gage – Washington University School of Medicine St. Louis

  Co-Author: Kristen Sanfilippo, MD, MPHS – Washington University School of Medicine St. Louis